Promising New Cancer Drug Targets Tumor Genetics: VT Expert miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New cancer drug shows promise targeting genetic weakness in tumors medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes are away, cells may go astray.
E-Mail
IMAGE: Liwu Li, Yanxin Pei, Susan Campbell, and Yuan Zhu were awarded funding through the new pilot research program. view more
Credit: Virginia Tech
Children s National Hospital and Virginia Tech have awarded two $50,000 one-year pilot grants to multi-institutional teams of scientists for pediatric brain cancer research.
The inter-institutional program, which launched in December, promotes cross-disciplinary collaborations among researchers at both institutions. At Virginia Tech, the program is part of the Virginia Tech Cancer Research Alliance. Financial support for the program was provided by the offices of the Physician-in-Chief and Chief Academic Officer at Children s National, and by Virginia Tech s Office of the Vice President for Health Sciences and Technology.